Arbutus Biopharma





After Hours:




Please Login or Register

Login|Register FREE

Stock Price
Open: 6.10
Prev. Close: 6.10
Low/Hi: 5.68 - 6.15
52-Week: 3.20 - 8.25
Equity: 164,563
90-Day Avg: 169,436
90-Day Avg: 117
Todays Stock Vol: 77.6
20-Day (HV): 53.3
52-Week (HV): 68.0
30-Day IV: 58.8 -6.4
IV Pct Rank: 37% Subdued
Div. Yield:
Earnings: 3-Aug (Est.)
P/E Ratio:
Market Cap: 336.5 M
Short Int Pct: 0.0%
Pct Held By Inst.: 98.2%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ABUS

Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease.
Primary Exchange: NASDAQ
NAICS Pharmaceutical Preparation Manufacturing

ABUS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 362.1 M 3.62084E+08 203 203 0.02% 0.000193656 148 K 147925
IBB iShares Nasdaq Biotechnology Index Fund 9.0 B 8.96125E+09 192 192 0.05% 0.0005 4.1 M 4055170
PZI PowerShares Zacks Micro Cap 20.2 M 2.02E+07 400 400 0.27% 0.00274 55 K 55333
UBIO Proshares UltraPro Nasdaq Biotechnology 38.1 M 3.80733E+07 197 197 0.01% 0.000114714 14 K 13975

Wait, Before You Leave...

Want to Know More About ABUS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon